November December 2011

Teaser

January February 2012

Teaser

March April 2012

Teaser

RSSNews // First PBA Treatment Approved

Nuedexta (dextromethorphan hydrobromide and quinidine sulfate, Avanir) received FDA approval as the first treatment for pseudobulbar affect (PBA). Studies to support the effectiveness of Nuedexta ...

more >

Mission Statement

Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.